Recent findings indicate that metformin activates AMPK/SIRT1 signaling, promotes NF-κB expression, and induces caspase-3/GSDME-mediated pyroptosis in various cancer cells, including hepatoblastoma, colon cancer, and breast cancer cells [202]. This evidence concerns the gene GSDME and breast carcinoma.